News
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...
43m
InvestorsHub on MSNGSK shares rise after FDA grants priority review for oral gonorrhea antibiotic
GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results